Nature Communications (Feb 2019)
Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo
Abstract
The peptide hormone GLP-1 has the potential to be a remedy for diabetes type II, yet is unstable. Here, the authors synthesized α-peptide-oligourea hybrid analogues of GLP-1 some of which showing significantly prolonged activity in vivo.